相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Potent antiproliferative activity of bradykinin B2 receptor selective agonist FR-190997 and analogue structures thereof: A paradox resolved?
Gerasimos Rassias et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
Bruce Zuraw et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
PHA-022121, a First in Class Oral Bradykinin B2 Receptor Antagonist in Clinical Development: Proof of Concept Study in a Translational Monkey Bradykinin Challenge Model
Anne Lesage et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
In VitroPharmacological Profile of a New Small Molecule Bradykinin B(2)Receptor Antagonist
Anne Lesage et al.
FRONTIERS IN PHARMACOLOGY (2020)
Current and emerging biologics for the treatment of hereditary angioedema
Francesca Perego et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2019)
Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N-terminal cleavage site of bradykinin
Konrad Bork et al.
ALLERGY (2019)
Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics
Itahisa Marcelino-Rodriguez et al.
FRONTIERS IN GENETICS (2019)
Kallikrein/K1, Kinins, and ACE/Kininase II in Homeostasis and in Disease Insight From Human and Experimental Genetic Studies, Therapeutic Implication
Francois Alhenc-Gelas et al.
FRONTIERS IN MEDICINE (2019)
A missense mutation in the plasminogen gene, within the plasminogen kringle 3 domain, in hereditary angioedema with normal C1 inhibitor
Georg Dewald
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
How is the human umbilical artery regulated?
Margarida Lorigo et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2018)
Bifunctional ligands of the bradykinin B2 and B1 receptors: An exercise in peptide hormone plasticity
Francois Marceau et al.
PEPTIDES (2018)
D-Arg0-Bradykinin-Arg-Arg, a Latent Vasoactive Bradykinin B2 Receptor Agonist Metabolically Activated by Carboxypeptidases
Helene Bachelard et al.
FRONTIERS IN PHARMACOLOGY (2018)
Hereditary angioedema with a mutation in the plasminogen gene
K. Bork et al.
ALLERGY (2018)
Pathogenesis of Hereditary Angioedema The Role of the Bradykinin-Forming Cascade
Allen P. Kaplan et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2017)
Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B2 receptor and peptidase resistance in rats
Xavier Charest-Morin et al.
PEERJ (2017)
New insights into the stereochemical requirements of the bradykinin B2 receptor antagonists binding
Cecylia S. Lupala et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2016)
The isolated human umbilical vein as a bioassay for kinin-generating proteases: An in vitro model for therapeutic angioedema agents
Melissa Jean et al.
LIFE SCIENCES (2016)
In Vivo Effects of Bradykinin B2 Receptor Agonists with Varying Susceptibility to Peptidases
Melissa Jean et al.
FRONTIERS IN PHARMACOLOGY (2016)
Involvement of Extracellular Signal-Regulated Kinase 5 in Kinin B1 Receptor Upregulation in Isolated Human Umbilical Veins
Yael Kilstein et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Pharmacological effects of recombinant human tissue kallikrein on bradykinin B2 receptors
Xavier Charest-Morin et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
FR-190997, a Nonpeptide Bradykinin B2-Receptor Partial Agonist, is a Potent and Efficacious Intraocular Pressure Lowering Agent in Ocular Hypertensive Cynomolgus Monkeys
Najam A. Sharif et al.
DRUG DEVELOPMENT RESEARCH (2014)
Pharmacological evidence of bradykinin regeneration from extended sequences that behave as peptidase-activated B2 receptor agonists
Xavier Charest-Morin et al.
FRONTIERS IN PHARMACOLOGY (2014)
Vasopeptidase-activated latent ligands of the histamine receptor-1
Lajos Gera et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Plasma kallikrein: the bradykinin-producing enzyme
Jenny Bjorkqvist et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Selective Kinin Receptor Agonists as Cardioprotective Agents in Myocardial Ischemia and Diabetes
Louis Potier et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Prolonged signalling and trafficking of the bradykinin B2 receptor stimulated with the amphibian peptide maximakinin: Insight into the endosomal inactivation of kinins
Marie-Therese Bawolak et al.
PHARMACOLOGICAL RESEARCH (2012)
A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor
Konrad Bork et al.
CLINICAL IMMUNOLOGY (2011)
Design of Fluorescent Bradykinin Analogs: Application to Imaging of B2 Receptor-Mediated Agonist Endocytosis and Trafficking and Angiotensin-Converting Enzyme
Lajos Gera et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Met-Lys-bradykinin-Ser-Ser, a peptide produced by the neutrophil from kininogen, is metabolically activated by angiotensin converting enzyme in vascular tissue
Lajos Gera et al.
PHARMACOLOGICAL RESEARCH (2011)
Cardioprotective Effects of a Selective B2 Receptor Agonist of Bradykinin Post-Acute Myocardial Infarct
Maria Marketou et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Effect of interferon-γ on inflammatory cytokine-induced bradykinin B1 receptor expression in human vascular cells
Geremy Abdull Koumbadinga et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Cardioprotective properties of bradykinin: role of the B2 receptor
Athanasios J. Manolis et al.
HYPERTENSION RESEARCH (2010)
Ecallantide for the Treatment of Acute Attacks in Hereditary Angioedema
Marco Cicardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A ligand-based approach to investigate the expression and function of angiotensin converting enzyme in intact human umbilical vein endothelial cells
Geremy Abdull Koumbadinga et al.
PEPTIDES (2010)
Effects of inactivation-resistant agonists on the signalling, desensitization and down-regulation of bradykinin B2 receptors
Marie-Therese Bawolak et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency
Fleur Bossi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Neutrophil-Derived Proteinase 3 Induces Kallikrein-Independent Release of a Novel Vasoactive Kinin
Robin Kahn et al.
JOURNAL OF IMMUNOLOGY (2009)
The kallikrein-kinin system in health and in diseases of the kidney
Masao Kakoki et al.
KIDNEY INTERNATIONAL (2009)
Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor
Simon Belanger et al.
PEPTIDES (2009)
Novel kinin B1 receptor agonists with improved pharmacological profiles
Jerome Cote et al.
PEPTIDES (2009)
Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema
R. M. Fryer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
A fluorescent version of the bradykinin B2 receptor antagonist B-9430:: Pharmacological characterization and use in live cell imaging
Marie-Therese Bawolak et al.
PEPTIDES (2008)
B-9972 (D-Arg-[Hyp3, IgI5, Oic7, IgI8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3, IgI5, D-IgI7, Oic8]-bradykinin):: Pharmacologic profile and effective induction of receptor degradation
Marie-Therese Bawolak et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Does zaltoprofen antagonize the bradykinin receptors?
Marie-Therese Bawolak et al.
REGULATORY PEPTIDES (2007)
Functional evidence of des-Arg10-kallidin enzymatic inactivating pathway in isolated human umbilical vein
Wanda Nowak et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2007)
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
Masao Kakoki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Role of nuclear factor-κB and protein kinase C signaling in the expression of the kinin B1 receptor in human vascular smooth muscle cells
Marie Eve Moreau et al.
MOLECULAR PHARMACOLOGY (2007)
Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia
V Griol-Charhbili et al.
FASEB JOURNAL (2005)
International union of pharmacology.: XLV.: Classification of the kinin receptor family:: from molecular mechanisms to pathophysiological consequences
LMF Leeb-Lundberg et al.
PHARMACOLOGICAL REVIEWS (2005)
The kallikrein-kinin system: Current and future pharmacological targets
ME Moreau et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
Discovery of the first non-peptide full agonists for the human bradykinin B2 receptor incorporating 4-(2-picolyloxy)quinoline and 1-(2-picolyl)benzimidazole frameworks
Y Sawada et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Bradykinin receptor ligands: Therapeutic perspectives
F Marceau et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction
KK Veeravalli et al.
PHARMACOLOGICAL RESEARCH (2004)
A non-peptide antagonist unusually selective for the human form of the bradykinin B2 receptor
F Marceau et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin
M Pretorius et al.
CIRCULATION (2003)
Expression of kinin B1 receptor in fresh or cultured rabbit aortic smooth muscle:: role of NF-κB
T Sabourin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Further pharmacological evidence of nuclear Factor-κB pathway involvement in bradykinin B1 receptor-sensitized responses in human umbilical vein
SP Sardi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Nonpeptide bradykinin B2 receptor antagonists:: Conversion of rodent-selective bradyzide analogues into potent, orally-active human bradykinin B2 receptor antagonists
EK Dziadulewicz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Bradykinin and des-Arg9-bradykinin metabolic pathways and kinetics of activation of human plasma
M Cyr et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)
Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice
S Bergaya et al.
CIRCULATION RESEARCH (2001)
Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice
P Meneton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins
C Blais et al.
PEPTIDES (2000)
Human bradykinin B2 receptor is activated by kallikrein and other serine proteases
C Hecquet et al.
MOLECULAR PHARMACOLOGY (2000)
Bradyzide, a potent non-peptide B-2 bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia
GM Burgess et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
分享论文
